Mesulid Tablets

Description

Indications

Mesulid Tablets is primarily indicated in conditions like Bursitis, Fever, fever, Gynecological infections, Inflammation, Osteoarthritis, Pain, Rheumatoid arthritis, Tendinitis, Thrombophlebitis, Trauma, and can also be given in adjunctive therapy as an alternative drug of choice in Ent infections.

Contraindication

Mesulid Tablets is contraindicated in conditions like Gl ulceration, Gl hemorrhage.

Side Effects

The severe or irreversible adverse effects of Mesulid Tablets, which give rise to further complications include Stevens johnson syndrome, lyells syndrome, hepatoxicity. Mesulid Tablets produces potentially life-threatening effects which include Anaphylaxis. which are responsible for the discontinuation of Mesulid Tablets therapy. The signs and symptoms that are produced after the acute overdosage of Mesulid Tablets include Hypotension, Hypothermia. The symptomatic adverse reactions produced by Mesulid Tablets are more or less tolerable and if they become severe, they can be treated symptomatically, these include Headache, Drowsiness, Nausea, Pain, Vertigox, Thrombocytopenia, Melena.

Warnings

Mesulid Tablets must be used with care among patients with a history of bleeding, with illnesses of the upper gastrointestinal tract and to subjects undergoing treatment with anticoagulants or drugs that inhibit platelet aggregation. The patients must be under direct medical supervision while taking substances with limited gastric tolerance at the same time. Since the drug is eliminated mainly through the kidneys, patient with the renal insufficiency must have a lower dosage depending on the glomerular filtration rate. The product must not be administered to the patient with severe renal insufficiency. The product can cause water retention, therefore it must not be administered to the patient with reduced cardiac function. Patients whose activity require alertness must take the product with care in case they notice drowsiness or vertigo during therapy. Cases of visual disturbances when using other non-steroidal anti-inflammatory drugs have been reported, If eye problems appear, the treatment must be interrupted and an eye examination must be performed.